(Total Views: 747)
Posted On: 07/20/2022 2:09:11 PM
Post# of 155571
My guess would be if they were smart enough to partner with a small biotech that has had the decks stacked against them publicly as we all know, then they would indeed be smart enough to help CYDY realize the full potential of Leronlimab.
They will be going in with eyes wide open.
I know you know this, but as a refresher for others or newbies - read Tony Wood's bio here
https://www.gsk.com/en-gb/media/press-release...gnate-gsk/
"He invented maraviroc, a CCR5 antagonist for the treatment of HIV and Pfizer’s first successful drug derived from high-throughput screening. It is one of the first examples of a genetically inspired medicine."
They will be going in with eyes wide open.
I know you know this, but as a refresher for others or newbies - read Tony Wood's bio here
https://www.gsk.com/en-gb/media/press-release...gnate-gsk/
"He invented maraviroc, a CCR5 antagonist for the treatment of HIV and Pfizer’s first successful drug derived from high-throughput screening. It is one of the first examples of a genetically inspired medicine."
(7)
(0)
